CACCURI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 4.609
EU - Europa 1.739
AS - Asia 804
AF - Africa 15
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
Totale 7.189
Nazione #
US - Stati Uniti d'America 4.596
IT - Italia 472
CN - Cina 463
UA - Ucraina 381
PL - Polonia 238
DE - Germania 182
HK - Hong Kong 170
FI - Finlandia 132
SG - Singapore 112
GB - Regno Unito 94
IE - Irlanda 90
FR - Francia 68
BE - Belgio 25
CZ - Repubblica Ceca 21
SE - Svezia 20
IN - India 19
CA - Canada 13
VN - Vietnam 13
TR - Turchia 11
AU - Australia 10
ET - Etiopia 7
EU - Europa 6
IR - Iran 3
KR - Corea 3
MU - Mauritius 3
NO - Norvegia 3
RU - Federazione Russa 3
AR - Argentina 2
BR - Brasile 2
CM - Camerun 2
EE - Estonia 2
JO - Giordania 2
NL - Olanda 2
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
ZA - Sudafrica 1
Totale 7.189
Città #
Fairfield 717
Woodbridge 504
Ashburn 356
Seattle 343
Houston 308
Cambridge 298
Jacksonville 288
Ann Arbor 270
Chandler 255
Warsaw 238
Wilmington 238
Brescia 186
Hong Kong 169
Princeton 167
New York 126
Beijing 116
Helsinki 101
Dublin 90
Singapore 76
Dearborn 62
Nanjing 60
Shanghai 58
San Diego 34
Des Moines 32
Hebei 31
Nanchang 29
Boardman 26
Brussels 24
Changsha 23
Jinan 23
Brno 20
Shenyang 20
London 19
Milan 17
Tianjin 16
Jiaxing 15
Munich 14
Dong Ket 12
San Francisco 12
Rome 10
Kocaeli 9
Kunming 9
Los Angeles 9
Verona 9
Haikou 8
Kilburn 8
Taizhou 8
Zhengzhou 8
Auburn Hills 7
Castiglione Delle Stiviere 7
Falls Church 7
Ningbo 7
Redwood City 7
Toronto 7
Norwalk 6
Porto 6
Guangzhou 5
Gunzenhausen 5
Hangzhou 5
Hefei 5
Lanzhou 5
Montelabbate 5
Ottawa 5
Turin 5
Lancaster 4
Lappeenranta 4
New Bedfont 4
Orange 4
Pune 4
As 3
Bergamo 3
Chicago 3
Detroit 3
Falkenstein 3
Florence 3
Glasgow 3
Melbourne 3
Redmond 3
Rende 3
Spoltore 3
Sydney 3
Taranto 3
Udine 3
Villanuova Sul Clisi 3
Amman 2
Ardabil 2
Bedizzole 2
Canberra 2
Caserta 2
Cazzago San Martino 2
Chiswick 2
Chongqing 2
Ferrara 2
Giarre 2
Indiana 2
Leawood 2
Napoli 2
Nürnberg 2
Oggiono 2
Padova 2
Totale 5.662
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 277
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy 211
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 164
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 158
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 142
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 142
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. 131
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 129
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 129
A cluster of invasive listeriosis in Brescia, Italy. 128
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 122
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 122
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 121
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 120
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition 120
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 116
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. 114
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 112
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 111
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 111
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 110
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 109
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 107
HIV-1 matrix protein p17 and its receptors. 106
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 106
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones 105
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 105
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. 104
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 102
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 101
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 98
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 98
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 97
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 96
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 96
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 96
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 95
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 95
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 95
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 94
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 93
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation 91
Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. 91
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 90
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 87
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 86
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 86
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120 85
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. 83
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids 83
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report 83
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants 82
Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae" 81
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 78
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 78
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 74
Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G 73
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 64
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 63
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 63
HIV-1 infection, microenvironment and endothelial cell dysfunction. 59
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 59
A topical desiccant agent in association with ultrasonic debridement in the initial treatment of chronic periodontitis: a clinical and microbiological study 56
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 56
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 52
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 51
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 48
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 46
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 38
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 37
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 35
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket 34
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 32
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 32
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 31
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 27
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 26
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 24
The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier 24
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 22
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 21
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 20
Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations 18
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 18
Viral proteins as emerging cancer therapeutics 17
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy 16
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 16
Covid-19 ocular prophylaxis: The potential role of ozonated-oils in liposome eyedrop gel 15
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 14
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era 13
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight 12
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 12
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 11
Traceability of SARS-CoV-2 transmission through quasispecies analysis 11
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 10
Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection 10
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion 9
Tlr3 and tlr7 rna sensor activation during sars-cov-2 infection 9
Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2 8
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 6
Totale 7.464
Categoria #
all - tutte 38.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.804 191 59 64 173 114 205 189 206 142 261 86 114
2020/20211.622 17 240 108 153 48 132 155 238 123 192 147 69
2021/2022845 71 129 9 47 17 34 45 83 32 94 63 221
2022/2023839 121 11 28 54 77 199 4 107 142 2 52 42
2023/2024895 61 18 75 65 46 141 50 43 184 26 46 140
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 7.483